When preparing your proposal, please note that the 10-page document must now be single-spaced. Additionally, Pfizer has clarified that awarded funds cannot be used for capital purchases, equipment, or Pfizer products. Finally, if you need to email the Grant Officer with questions, be sure to use the newly required subject line “Providing Appropriate Medical Care for IBD Patients”.
Funder: Pfizer Inc.
Due Dates: March 30, 2026 (Submission deadline) | April 19, 2026 (Extended submission deadline)
Funding Amounts: Up to 2 million JPY per project; project duration up to 2 years (June 1, 2026 – May 31, 2028)
Summary: Supports quality improvement projects in Japan to enhance systems, collaboration, and expertise among healthcare professionals providing care to IBD patients.
Key Information: Only organizations in Japan are eligible; clinical research or drug efficacy studies are not supported.